IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Cutting-Edge Nanotechnology in Oncology Therapy Advancements and Application: Targeted Drug Delivery System

Cutting-Edge Nanotechnology in Oncology Therapy Advancements and Application: Targeted Drug Delivery System
View Sample PDF
Author(s): P. Selvakumar (Department of Science and Humanities, Nehru Institute of Technology, Coimbatore, India), Varsha D. Satav (JSPM University, Pune, India), Akki Rajasekhar Reddy (Sai Rajeswari Institute of Technology, India), Shanmugarathinam Alagarsamy (University College of Engineering, BIT Campus, Anna University, Tiruchirappalli, India)and Sumanta Bhattacharya (Maulana Abul Kalam Azad University of Technology, India)
Copyright: 2025
Pages: 14
Source title: Exploring Nanomaterial Synthesis, Characterization, and Applications
Source Author(s)/Editor(s): Krishnaraj Ramaswamy (Dambi Dollo University, Ethiopia), N. Nagaprasad (ULTRA College of Engineering and Technology, India)and Shanmugam Ramaswamy (JSS College of Pharmacy, India)
DOI: 10.4018/979-8-3693-6326-3.ch015

Purchase

View Cutting-Edge Nanotechnology in Oncology Therapy Advancements and Application: Targeted Drug Delivery System on the publisher's website for pricing and purchasing information.

Abstract

The study's goal was to discuss current research on nanoparticles and the different kinds of nanoparticles that can be used to deliver medications via parenteral infusion. The use of nanoparticles in fitness sciences and pharmacy, such as in targeted therapy and cancer therapy, is very beneficial for the advancement of the healthcare system. Along with reducing toxicity, enhancing release, and providing better formulation options, it helps to increase the solubility and bioavailability of medications. Several profitable oral medications have been developed using nanoparticles technology to enhance API absorption. Nano-milling progression is used to increase absorption of nano-parenteral. In oncology, dynamic target is beneficial because it can minimise side effects, especially when treating malignancies. By modifying cancer immunotherapy, this system is expected to soon offer new therapeutic options.

Related Content

Abel Saka Gungure, Leta Tesfaye Jule. © 2025. 28 pages.
Yogesh K. Kadam, Kinjal D. Solanki, Mihar S. Shaikh, Ashwini M. Savle, Naved I. Malek, Neelam Mishra. © 2025. 32 pages.
Yonas Etafa Tasisa, Gunasekaran Muniappan, Ramaswamy Krishnaraj, Senbeto Kena. © 2025. 18 pages.
Ramya Gade, Lahari Priya M., Lalitha Priyanka Dwarampudi, K. Yamuna, Nagasa Maraba, Gamachu Fufa. © 2025. 22 pages.
Abel Saka Gungure, Leta Tesfaye Jule. © 2025. 24 pages.
Shuma Fayera Wirtu, Leta Tesfaye Jule, Nagaprasad Nagaraj. © 2025. 26 pages.
Dharmendra Kumar, Shweta Mukherjee, Avirup Das. © 2025. 18 pages.
Body Bottom